1 / 4
文档名称:

Fatal Microangiopathic Hemolytic Anemia Due to Sézary Syndrome 2021 Jake C Robertson.pdf

格式:pdf   大小:543KB   页数:4页
下载后只包含 1 个 PDF 格式的文档,没有任何的图纸或源代码,查看文件列表

如果您已付费下载过本站文档,您可以点这里二次下载

Fatal Microangiopathic Hemolytic Anemia Due to Sézary Syndrome 2021 Jake C Robertson.pdf

上传人:周太监 2023/1/28 文件大小:543 KB

下载得到文件列表

Fatal Microangiopathic Hemolytic Anemia Due to Sézary Syndrome 2021 Jake C Robertson.pdf

相关文档

文档介绍

文档介绍:该【Fatal Microangiopathic Hemolytic Anemia Due to Sézary Syndrome 2021 Jake C Robertson 】是由【周太监】上传分享,文档一共【4】页,该文档可以免费在线阅读,需要了解更多关于【Fatal Microangiopathic Hemolytic Anemia Due to Sézary Syndrome 2021 Jake C Robertson 】的内容,可以使用淘豆网的站内搜索功能,选择自己适合的文档,以下文字是截取该文章内的部分文字,如需要获得完整电子版,请下载此文档到您的设备,方便您编辑和打印。OpenAccessCase
ReportDOI:
FatalMicroangiopathicHemolyticAnemiaDueto
SézarySyndrome
,,LoriSoma2,AndreiShustov3,
,UniversityofWashington,Seattle,,Departmentof
Pathology,UniversityofWashington,Seattle,,DepartmentofMedicine,Universityof
Washington,Seattle,,DepartmentofMedicine,UniversityofWashington,Seattle,USA
Correspondingauthor:,******@
Abstract
Sézarysyndrome(SS)isaformofcutaneousT-celllymphoma(CTCL),demonstratingleukemicinvolvement
ofmalignantT--inducedanemia,
normocyticanemiasecondarytobonemarrowinfiltration,,
initiallydemonstratingwidespreadmorbilliformeruption,whopresentedwithmalignancy-related
microangiopathichemolyticanemia(MAHA).OurfindingsrepresentanovelpresentationofSSthatwill
informthedifferentialdiagnosisandtreatmentoffutureSSpatientspresentingwithanemiaand
thrombocytopenia.
Categories:Dermatology,Oncology
Keywords:sézarysyndrome,lymphoma,anemia,thrombocytopenia,hemolysis
Introduction
Sézarysyndrome(SS)isasubtypeofcutaneousT-celllymphoma(CTCL)primarilyoriginatingfrommatured
T-lymphocytesthatarepresentintheskinandblood[1].SSaffectsolderpatientsprimarilyovertheageof
60,ismorecommoninmales,andhasanincidenceofabout3:1,000,000intheUS[2].Whileanemiaand
thrombocytopeniahavepreviouslybeenreportedinpatientswithSSsecondarytobonemarrowinfiltration,
autoimmunehemolysis,ortreatmentwithparticularantineoplasticagents,therehavenotbeenprevious
reportsofamicroangiopathichemolyticanemia(MAHA)secondarytoprimarySS[3].
CasePresentation
A77-year-oldfemalewasdiagnosedwithSSonthebasisofapruritic,subtlebutwidespreadmorbilliform

-cell
populationofCD4+/CD5+T-cells,withaCD4/,
withaSézarycountof6,600cells/µ
Reviewbegan04/15/%usedoncedaily,
Reviewended06/04/2021wasfollowedcloselywithphysicalexamsandlaboratorystudiesandnotedoverthenextseveralyearsto
Published06/06/2021haveaslowincreaseincirculatingSézarycountandelevationoftheCD4/
©Copyright2021concomitantdecreaseintheoverallpercentofnaturalkiller(NK)cellsandmildthrombocytopeniawithout
.
articledistributedunderthetermsofthe
CreativeCommonsAttributionLicense
Threeyearsafterherinitialpresentation,thepatientpresentedwithfatigue,shortnessofbreath,andlower
CC-.,whichpermitsunrestricted
use,distribution,
medium,providedtheoriginalauthorandhematocritof12%,/µL,ameancorpuscularvolume(MCV)of
,aredcelldistributionwidth(RDW),aplateletcountof138,000cells/µL,anabsolute
/µL,alactatedehydrogenase(LDH)at262units/L,µmol/L,
andahaptoglobinat35mg/(DAT)(Figures
1A,1B)atthetimerevealedmarkedinvolvementbyherT-cellneoplasmwithover70%Sézarycellsby
morphology;%T-cellswithslightlydecreased
expressionofCD2,uniformlypositiveexpressionofCD4,slightlyincreasedexpressionofCD5,variably
decreasedexpressionofCD7,(Figure2).
Withthepatient’selevatedLDH,decreasedhaptoglobin,schistocytes,negativeCoombs,nearupperlimit
reticulocytecount,andsevereanemia,shewasdiagnosedwithanon-autoimmune,MAHAinthesettingof
SS.
Howtocitethisarticle
RobertsonJC,JafryMA,SomaL,etal.(June06,2021)FatalMicroangiopathicHemolyticAnemiaDuetoSé(6):

FIGURE1:Bonemarrowbiopsyshowsinfiltrationwith70%Sézarycells
bymorphology.(A)x10magnificationand(B)x40magnification.
FIGURE2:Peripheralbloodsmearshowsthepresenceofschistocytes,
indicativeofamicroangiopathic-hemolyticprocess.


months,herhemoglobinandplateletlevelshadstabilizedwithoutfurthertransfusion,andsheremained


presentation.
Discussion
SShasbeenassociatedwithhemophagocyticsyndrome-inducedanemia,normocyticanemiasecondaryto
bonemarrowinfiltration,andpancytopenia[4-6].Thromboticthrombocytopenicpurpura-hemolyticuremic
syndrome(TTP-HUS)hasbeenobservedasdose-dependenttoxicityofpentostatintreatmentforSS[7].
However,nosingle,commonformofanemiahasbeenfoundtobepresentinallSSpatients.
Otherdiagnosesconsideredinthedifferentialdiagnosisforourpatientincludedanemiasecondaryto

advanceddisease,thepatienthadanelevatedreticulocytecount,demonstratingcapacityforbonemarrow

patientswithSS[8].Inthiscase,thepatient’,thepresenceofschistocytesonthe
(6):
(HUS)and
thromboticthrombocytopenicpurpura(TTP)weregivenconsiderationinthiscontext,butwithnormalrenal
functionandnegativefeverorneurologicsymptoms,bothdiagnoseswereessentiallyexcluded.
Malignancy-associatedMAHAhasbeenpreviouslyreported[9-11].Themostcommonmalignancies
associatedincludecolon,gastric,prostate,lung,andcarcinomaofunknownprimary(CUP).Inmanyofthese
cases,MAHAwasoneofthefirstpresentationsofmalignancy,andextensiveworkupforTTP,HUS,and
disseminatedintravascularcoagulation(DIC)
fortheassociationofMAHAandmalignancyincludearteriolarorcapillaryswellingsecondarytoendothelial
damageofthemarrowvasculaturefromtheinvasionofthemalignancy,leadingtotheproductionoflarge
VonWillebrandFactor(VWF)multimersandsubsequentlycreatingamicroangiopathichemolyticprocess
similartoTTP[9,10,12].Similarly,ithasbeenproposedthattumoremboliorintraluminalfibrinthrombi
secondarytohypercoagulationmayleadtodirectbloodvesseldamage,creatinganenvironmentforRBC
fragmentation[9,10,12,13].Inthecaseofgastriccancers,theproductionofendothelium-damagingmucin
hasbeenproposedasapotentialmechanismfordirectbloodvesseldamage[14].
Theprimarytreatmentformalignancy-associatedMAHAisthetreatmentoftheunderlyingmalignancy
[9,10].Inmanycases,controloftheprimarymalignancyhassubsequentlycontrolledthehemolyticanemia
andstabilizedbloodcounts[15].TreatmentsutilizedforTTP-HUS,suchasrecombinantADAMTS13and
plasmaexchange,havebeenshowntodemonstrateefficacyintreatingmalignancy-associatedMAHA[16].
Theaveragesurvivalofmalignancy-relatedMAHAisfourmonthsforpatientsreceivinganti-cancertherapy
(includingchemotherapyorcancersurgery),-cancertherapy,
withassociatedsubgroupvariationbytypeofmalignancy[15].
Conclusions
Inconclusion,wepresentacaseofapatientwithSSpresentingwithmalignancy-
importantfortreatinghematologists/oncologistsanddermatologistswhoencounterpatientswithanemia
andthrombocytopeniainthesettingofSStonotonlyruleoutHUS,TTP,andanemiasecondarytodirect
infiltrationofthebonemarrow,
malignancy-associatedMAHAprimarilyincludescontroloftheunderlyingmalignancy;furtherinvestigation
isrequiredtodetermineefficacioustreatmentmodalitiesspecifictomalignancy-associatedMAHA.
AdditionalInformation
Disclosures
Humansubjects::In
compliancewiththeICMJEuniformdisclosureform,allauthorsdeclarethefollowing:Payment/services
info:Allauthorshavedeclaredthatnofinancialsupportwasreceivedfromanyorganizationforthe
:Allauthorshavedeclaredthattheyhavenofinancial
relationshipsatpresentorwithinthepreviousthreeyearswithanyorganizationsthatmighthavean
:Allauthorshavedeclaredthattherearenoother
relationshipsoractivitiesthatcouldappeartohaveinfluencedthesubmittedwork.
References
,KohHK:Sézarysyndrome:diagnosis,prognosis,
,22:381--9622(90)70054-l
,DevesaSS,AndersonWF,ToroJR:CutaneouslymphomaincidencepatternsintheUnited
States:apopulation-,113:5064--2008-10-184168
,SeymourJF,WolfM,etal.:Treatmentofpatientswithadvancedmycosisfungoidesand
Sé,71:250--
,Beylot-BarryM,D'IncanM,LarocheL:Lymphoma-associatedhemophagocyticsyndrome(LAHS)in
advanced-stagemycosisfungoides/SézarysyndromecutaneousT-.
2011,65:404-.
,Beylot-BarryM,ThiébautR,etal.:Bonemarrowhistopathologicandmolecularstagingin
epidermotropicT-,119:414-
,SuttonDM,PantalonyD:Sezarysyndromeinapatientwithhairycellleukemiainremission.
,68:829-33.
,PhamT,DiamandidisD,GeorgeJN:Thromboticthrombocytopenicpurpura-hemolyticuremic
syndrome(TTP-HUS)followingtreatmentwithdeoxycoformycininapatientwithcutaneousT-cell
lymphoma(Sezarysyndrome):,61:268-/(sici)1096-
8652(199908)61:4<268::aid-ajh9>;2-o
,AlbertF,BazarL,SulicaV,SacherRA:AutoimmunehemolyticanemiapresentinginSézary
,88:46-
:Systemicmalignanciesasacauseofunexpectedmicroangiopathichemolyticanemiaand
(WillistonPark).2011,25:908-14.
,GeorgeJN:
,12:523-.012096
,EdgerlyCH,FedoriwY:Hemolyticanemiaandmetastaticcarcinoma:casereportandliterature
(6):
,45:132-
,OishiK:Microangiopathichemolyticanemiaassociatedwithmetastaticbreastcancer:case
,5:-016-2312-4
:.
2018,53:167-.
,BhatGR:Cancer-,
10:.649
,ObermeierHL:Cancer-relatedmicroangiopathichemolyticanemia:clinicalandlaboratory
(Baltimore).2012,91:195-
:ADAMTS-
,5:
(6):

最近更新

丘陵地区精品度假酒店设计研究的中期报告 2页

专利权人h指数研究——以世界百强企业为例的任.. 2页

粤教版七年级下第九章美洲第一节南北差异显著.. 22页

不同采伐强度白桦幼龄林林分结构的差异的中期.. 1页

不同精料日粮对奶牛瘤胃需氧及兼性厌氧菌和矿.. 1页

2024年讲先进人物事迹演讲稿8篇 32页

2024年观察的作文三年级300字模板8篇 8页

解方程时需要注意的常见答案形式 19页

管道技术培训资料 23页

2024年蒙氏大班教案数学推荐7篇 19页

舒适棉质家居睡袍搭配 27页

管理者演讲技巧培训课件 30页

2024年节约粮食的倡议书6篇 9页

2024年自我介绍大学生0字篇 11页

2024年背影优秀教案5篇 31页

2024年职场自我介绍模板7篇 9页

2024年美术课期末总结7篇 18页

管理学购买行为与决策教学资料 25页

2024年给爸爸的封信作文参考7篇 10页

管理学基础第11章激励理论及其应用 24页

2024年级音乐上册教学计划精选5篇 12页

2024年精选实用关于低保申请书范文篇 7页

2024年精选关于校园安全工作总结参考范文4篇 7页

管理学-关于领导风格 24页

2024年精选关于五一劳动节活动总结范文3篇 4页

2024年精选优秀关于转学申请书范文8篇 9页

2024年管理部门的工作计划8篇 28页

管理信息系统面向对象分析与设计 36页

参加消防培训,学会紧急疏散与抢救技巧 23页

2023年度小学生田径运动会开幕词范本13篇 16页